News & Articles
Selected Filters:
Infectious disease highlights from ESCMID Global 2025
Expert video interviews on the latest technological innovations for clinical labs
Gradientech distributor a.d.a. wins tenders for QuickMIC at two important Italian hospitals
QuickMIC systems have already been installed at both hospitals and are now in the process of being implemented in clinical routine
Antimicrobial resistance and the MRSA crisis: A silent pandemic demanding urgent global action
In this guest editorial, Microzone explores MRSA and the escalating crisis of antimicrobial resistance—demanding faster diagnostics, renewed stewardship, and urgent global action
Diagnostics for resurging vaccine-preventable diseases
Explore comprehensive serological & PCR assays for vaccine-preventable disease detection
Cytovale’s rapid diagnostic slashes sepsis mortality by 39%, peer-reviewed study confirms
Cytovale’s IntelliSep sepsis test highlights a new model for ED triage that’s already delivering systemwide clinical and economic value
The role of syndromic testing in advancing gastroenteritis diagnosis
In this guest editorial, Dr. Anurag Singh discusses gastroenteritis diagnosis and how syndromic testing is establishing its role in the future of infectious disease management
Wolters Kluwer introduces Ovid Guidelines AI, transforming clinical guideline development with agentic AI
Ovid Guidelines AI set to accelerate ASCO guideline research workflow with GenAI
Association for Molecular Pathology defines core bioinformatics competencies for clinical labs
Three interrelated Body of Knowledge papers outline roles and required skills for bioinformaticians with respect to molecular diagnostics, clinical bioinformatics, clinical laboratory regulation and data security
tHIS ASEAN 2025 makes its debut next week amid southeast Asia’s medical innovation surge
Over 200 exhibitors, AI-powered breakthroughs, and strategic forums set to transform regional healthcare
IBD diagnostic tools and best practices for healthcare providers
How cross-disciplinary collaboration and earlier recognition can transform outcomes for patients with Crohn’s disease and ulcerative colitis
MSACL notions on the evolution and future of clinical mass spectrometry
Experts discuss the evolving landscape of clinical mass spectrometry, the impact of automation, challenges in integration, and what the future holds
Standardizing metabolomics advances biomarker discovery
Discover how prioritizing reproducibility and method validation can empower researchers to unlock the full potential of metabolomics in advancing biomarker discovery and drug development
Revvity’s EUROIMMUN unveils new fully automated instrument for specialty testing
The IDS i20 platform offers fully automated processing of specialty assays in endocrinology, allergy, autoimmune and infectious diseases, Alzheimer’s disease and therapeutic drug monitoring
Tosoh Bioscience – Diagnostics EMEA launches new HbA1c analyzer
Due to its precise analytical performance, the HLC-723 GR01 enhances diagnostic confidence, supporting both high throughput and improved diabetes care
Optimer licensing agreements and repeat custom
Licensing with a global enzyme provider for two Optimer reagents in research and diagnostics
Greener clinical lab testing now within reach
New solutions from Siemens Healthineers address labs’ environmental and efficiency goals
QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software
The acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases
On cfDNA in hematologic cancers: A Q&A with Dr. Mark Murakami
Dr. Murakami discusses the molecular tools enabling the pursuit of precision medicine
Roche granted FDA Breakthrough Device Designation for first AI-driven companion diagnostic for non-small cell lung cancer
The VENTANA TROP2 (EPR20043) RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment
IBL International collaborates with Grifols on advanced biomarker panels
Grifols and IBL, a Tecan company, seek to revolutionize clinical diagnostics with a future high-sensitivity, multiplexed immunoassay platform
Mursla Bio receives FDA breakthrough device designation for EvoLiver test
Breakthrough status provides expedited review and closer collaboration with the FDA, ultimately enabling broader market reach and commercial adoption
Valley Diagnostics and Sona Nanotech sign Heads of Terms agreement to advance commercialization of Bovine TB Assay
Agreement represents a significant step towards bringing Sona’s bTB rapid test to the market at scale
























